{"id":"https://openalex.org/A5013294512","orcid":"https://orcid.org/0009-0001-9329-8656","observed_orcids":["https://orcid.org/0009-0001-9329-8656"],"display_name":"Maren Pr\u00fcfer","raw_author_names":["M Pr\u00fcfer","Maren Pr\u00fcfer","Pr\u00fcfer, Maren"],"full_name":"Maren Pr\u00fcfer","works_count":8,"cited_by_count":67,"summary_stats":{"2yr_mean_citedness":8.142857142857142,"h_index":5,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5013294512","orcid":"https://orcid.org/0009-0001-9329-8656","observed_orcids":["https://orcid.org/0009-0001-9329-8656"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210153469","ror":"https://ror.org/04xmnzw38","display_name":"Georg Speyer Haus","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]},"years":[2025,2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4210153469","ror":"https://ror.org/04xmnzw38","display_name":"Georg Speyer Haus","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","count":7,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","count":7,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","value":8.83e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","value":7.5e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":1.68e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","value":1.07e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","value":1.01e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","score":0.8518999814987183},{"id":"147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","score":0.5626245737075806},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.5254999995231628},{"id":"2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","score":0.5133000016212463},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.48809802532196045}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":2},{"year":2024,"works_count":4,"oa_works_count":3,"cited_by_count":8},{"year":2025,"works_count":3,"oa_works_count":2,"cited_by_count":24},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":33}],"display_name_alternatives":["M Pr\u00fcfer","Maren Pr\u00fcfer","Pr\u00fcfer, Maren"],"block_key":"m prufer","works_api_url":"https://api.openalex.org/works?filter=author.id:A5013294512","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5013294512","updated_date":"2026-11-12T13:17:38","created_date":"2023-01-23T00:00:00"}